Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?

Literature DB >> 11096126

Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?

P Ruggenenti, G Remuzzi.

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 11096126 DOI： 10.1093/ndt/15.12.1900

Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

Review 1. The genetics of diabetic complications.

Authors: Emma Ahlqvist; Natalie R van Zuydam; Leif C Groop; Mark I McCarthy
Journal: Nat Rev Nephrol Date: 2015-03-31 Impact factor: 28.314

2. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.

Authors: Ghada Al-Kafaji; Ghazi Al-Mahroos; Haifa Abdulla Al-Muhtaresh; Cristina Skrypnyk; Mohamed Abdalla Sabry; Ahmad R Ramadan
Journal: Exp Ther Med Date: 2016-05-26 Impact factor: 2.447

3. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.

Authors: Jaime J Jayapalan; Sekaran Muniandy; Siew P Chan
Journal: Indian J Hum Genet Date: 2010-05

Review 4. The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Authors: Marcel H A Muskiet; Mark M Smits; Linde M Morsink; Michaela Diamant
Journal: Nat Rev Nephrol Date: 2013-12-24 Impact factor: 28.314

5. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

Authors: Natalie R van Zuydam; Emma Ahlqvist; Niina Sandholm; Harshal Deshmukh; N William Rayner; Moustafa Abdalla; Claes Ladenvall; Daniel Ziemek; Eric Fauman; Neil R Robertson; Paul M McKeigue; Erkka Valo; Carol Forsblom; Valma Harjutsalo; Annalisa Perna; Erica Rurali; M Loredana Marcovecchio; Robert P Igo; Rany M Salem; Norberto Perico; Maria Lajer; Annemari Käräjämäki; Minako Imamura; Michiaki Kubo; Atsushi Takahashi; Xueling Sim; Jianjun Liu; Rob M van Dam; Guozhi Jiang; Claudia H T Tam; Andrea O Y Luk; Heung Man Lee; Cadmon K P Lim; Cheuk Chun Szeto; Wing Yee So; Juliana C N Chan; Su Fen Ang; Rajkumar Dorajoo; Ling Wang; Tan Si Hua Clara; Amy-Jayne McKnight; Seamus Duffy; Marcus G Pezzolesi; Michel Marre; Beata Gyorgy; Samy Hadjadj; Linda T Hiraki; Tarunveer S Ahluwalia; Peter Almgren; Christina-Alexandra Schulz; Marju Orho-Melander; Allan Linneberg; Cramer Christensen; Daniel R Witte; Niels Grarup; Ivan Brandslund; Olle Melander; Andrew D Paterson; David Tregouet; Alexander P Maxwell; Su Chi Lim; Ronald C W Ma; E Shyong Tai; Shiro Maeda; Valeriya Lyssenko; Tiinamaija Tuomi; Andrzej S Krolewski; Stephen S Rich; Joel N Hirschhorn; Jose C Florez; David Dunger; Oluf Pedersen; Torben Hansen; Peter Rossing; Giuseppe Remuzzi; Mary Julia Brosnan; Colin N A Palmer; Per-Henrik Groop; Helen M Colhoun; Leif C Groop; Mark I McCarthy
Journal: Diabetes Date: 2018-04-27 Impact factor: 9.461

10. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.

Authors: Meihua Yan; Yumin Wen; Liping Yang; Xi'ai Wu; Xiaoguang Lu; Bingxuan Zhang; Weiping Huang; Ping Li
Journal: Trials Date: 2016-05-23 Impact factor: 2.279

Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?

Review 1. The genetics of diabetic complications.

2. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.

3. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.

Review 4. The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

5. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

Review 6. Targeting the renin-angiotensin system in patients with renal disease.

7. p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin.

8. Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats.

9. Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.

10. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.